登录
  • #新闻|点评

牛津大学阿斯利康冠状病毒疫苗试验中的巴西志愿者死亡

指尖新闻
2555
8
巴西卫生当局Anvisa表示:冠状病毒疫苗研究中的一名巴西志愿者死亡。这一消息传出后,美国食品和药物管理局正在进行的一项阿斯利康公司的后期临床试验在美国暂停。阿斯利康股价也于周三转为负值。

阿斯利康的发言人以 "医疗保密和临床试验规定 "为由,拒绝对该志愿者发表评论。而与阿斯利康合作开发该疫苗的牛津大学发言人在一份声明中表示:在对巴西的死亡案例进行评估后,"没有对临床试验的安全性产生任何担忧"。牛津大学发言人Alexander Buxton表示:"除了巴西监管机构外,独立审查小组建议继续进行试验。"

AstraZeneca shares turned negative Wednesday after a Brazilian health authority, Anvisa, said a volunteer in its Brazilian coronavirus vaccine study died.

A spokesperson from AstraZeneca declined to comment on the volunteer, citing “medical confidentiality and clinical trial regulations.”In a statement, a spokesperson from the University of Oxford, which is developing the vaccine with AstraZeneca, said “there have been no concerns about safety of the clinical trial” after an assessment of the case in Brazil. “The independent review in addition to the Brazilian regulator have recommended that the trial should continue,” Oxford spokesperson Alexander Buxton said. source



指尖新闻:高信噪比,一目了然

新冠疫情追踪
8条回复
热度排序

发表回复